The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Regular Contributions
Activation of the GABAA Receptor Ameliorates the Cochlear Excitotoxicity Caused by Kainic Acid in the Guinea Pig
Shuhei SakaiKeiji TabuchiHidekazu MurashitaAkira Hara
Author information
JOURNAL FREE ACCESS

2008 Volume 215 Issue 3 Pages 279-285

Details
Abstract

Excitotoxicity is a major neurotoxic mechanism in cochlear disorders, including cochlear ischemic injury and acoustic injury. Kainic acid (KA), an excitatory amino acid, can damage glutamatergic neurons. The application of KA to the round window membrane, an opening of the cochlear bony labyrinth to the middle ear, induces excitotoxicity of cochlear afferent dendrites and significantly decreases the amplitude of compound action potential of the cochlea (CAP), a cochlear potential generated by activation of the auditory nerve fibers. On the other hand, muscimol, a gamma-aminobutyric acid (GABA)A receptor agonist, is neuroprotective in excitotoxicity in the central nervous system. Here we studied whether activation of GABA receptor decreased the excitotoxicity of the cochlea caused by KA. KA (10 mM) was applied to the round window membrane of guinea pigs for 30 minutes. Muscimol, bicuculline, a GABAA receptor antagonist, or baclofen, a GABAB receptor agonist, was given at the onset of KA application. The threshold shift of CAP was examined with chronically implanted electrodes. Application of KA significantly elevated the CAP threshold on day 1 and day 3 as compared with the pre-application level. Muscimol significantly decreased the KA-induced CAP threshold shifts. Furthermore, this protective effect of muscimol was inhibited by the application of bicuculline, a GABAA receptor antagonist. However, baclofen, a GABAB receptor agonist, did not affect the CAP threshold shifts caused by KA. These results suggest that activation of GABAA receptor could prevent cochlear excitotoxicity. GABAA rececptor activation may represent an effective treatment of cochlear ischemc injury and acoustic injury.

Content from these authors
© 2008 Tohoku University Medical Press
Previous article Next article
feedback
Top